D
Anika Therapeutics, Inc. ANIK
$15.11 -$0.39-2.52%
Recommendation
Sell
Prev Close
$15.11
Volume
49,069
Avg Vol (90D)
79,797
Market Cap
$214.20M
Dividend & Yield
--
52-Week Range
$14.95 - $29.12
P/E (TTM)
--
EPS (TTM)
-$3.85
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Anika Therapeutics Faces Financial Strain Amid Geopolitical Tensions and Supply Chain Disruptions
3/18/2025 - TipRanks Financial Blog
Anika Therapeutics (NASDAQ:ANIK) Rating Increased to Buy at StockNews.com
3/16/2025 - Ticker Report
Anika Therapeutics (ANIK, $15.91) RSI Indicator left the oversold zone on March 14, 2025
3/15/2025 - Tickeron - Stocks
Anika Therapeutics (NASDAQ:ANIK) Upgraded to Buy at StockNews.com
3/15/2025 - MarketBeat
Barrington Research Cuts Anika Therapeutics (NASDAQ:ANIK) Price Target to $20.00
3/14/2025 - MarketBeat
Anika Therapeutics (NASDAQ:ANIK investor three-year losses grow to 45% as the stock sheds US$26m this past week
3/14/2025 - Simply Wall St
Anika Therapeutics (ANIK, $15.21) RSI Indicator left the oversold zone on March 13, 2025
3/14/2025 - Tickeron - Stocks
Anika Therapeutics (ANIK, $15.21) price exceeded its 50-day Moving Average on March 13, 2025
3/14/2025 - Tickeron - Stocks
Anika Therapeutics (NASDAQ:ANIK) Issues Earnings Results
3/13/2025 - MarketBeat
The Math Shows SQLV Can Go To $51
3/13/2025 - ETF Channel
Anika Therapeutics price target lowered by $5 at Barrington, here's why
3/13/2025 - The Fly
Anika Therapeutics (ANIK, $17.11) price moved above its 50-day Moving Average on March 12, 2025
3/13/2025 - Tickeron - Stocks
Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges
3/13/2025 - GuruFocus
Q4 2024 Anika Therapeutics Inc Earnings Call Transcript
3/13/2025 - GuruFocus
Anika Therapeutics, Inc. (ANIK) Q4 2024 Earnings Call Transcript
3/12/2025 - Seeking Alpha: Transcripts
Anika Therapeutics, Inc. (ANIK) Q4 2024 Earnings Call Transcript
3/12/2025 - SeekingAlpha
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates
3/12/2025 - Zacks Investment Research
Anika Therapeutics, Inc. 2024 Q4 - Results - Earnings Call Presentation
3/12/2025 - SeekingAlpha
Anika Therapeutics reports Q4 EPS (3c), consensus 9c
3/12/2025 - The Fly
Anika Reports Fourth Quarter and Full Year 2024 Financial Results
3/12/2025 - Globe Newswire
Anika Therapeutics (ANIK, $16.79) RSI Indicator left the oversold zone on March 11, 2025
3/12/2025 - Tickeron - Technical Analysis
Anika Therapeutics (ANIK, $16.5) RSI Indicator left the oversold zone on March 10, 2025
3/11/2025 - Tickeron - Stocks
Anika Therapeutics (ANIK, $16.5) RSI Indicator left the oversold zone on March 10, 2025
3/11/2025 - Tickeron - Technical Analysis
Anika Therapeutics (ANIK, $16.62) price exceeded its 50-day Moving Average on March 07, 2025
3/8/2025 - Tickeron - Stocks
Analysts Offer Insights on Healthcare Companies: Myomo (MYO), Kymera Therapeutics (KYMR) and Anika Therapeutics (ANIK)
3/7/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$151.80M
EBITDA (TTM)
-$25.95M
EBIT (TTM)
-$34.45M
Net Income (TTM)
-$56.39M
Balance Sheet
Total Assets (Q)
$202.74M
Total Debt (Q)
$25.93M
Total Liabilities (Q)
$48.75M
Book Value Per Share (Q)
$10.68
Cash Flow
Cash from Operations (TTM)
$3.82M
Cash from Investing (TTM)
-$7.03M
Cash from Financing (TTM)
-$7.38M
Net Change in Cash (TTM)
-$10.50M
Filings
Filing Date
Monday, March 17, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
0.29
7-Day Total Return
-3.27%
30-Day Total Return
-15.40%
60-Day Total Return
-8.20%
90-Day Total Return
-12.41%
Year to Date Total Return
-6.79%
1-Year Total Return
-41.21%
2-Year Total Return
-47.06%
3-Year Total Return
-42.09%
5-Year Total Return
-47.04%
52-week Low
Mar 13, 2025 - $14.95
52-week High
Jul 18, 2024 - $29.12
Valuation
Market Cap
$214.20M - Micro Cap
Enterprise Value
$184.50M
Price/Sales (TTM)
1.46
Price/Book (Q)
1.41
Dividends and Shares
Shares Outstanding
14.62M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.anika.com
Phone Number
781 457 9000
Address
32 Wiggins Avenue
Bedford, MA 01730
Country
United States
Year Founded
1983
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative... more
NASDAQ 03/28/2025 4:00PM Eastern Quotes delayed
Weiss Ratings